What is the recommended treatment for pericarditis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Pericarditis

The first-line treatment for pericarditis consists of high-dose aspirin or NSAIDs combined with colchicine, with treatment duration guided by symptom resolution and CRP normalization. 1

First-Line Treatment

  • Aspirin (500-1000 mg every 6-8 hours, range 1.5-4 g/day) or ibuprofen (600 mg every 8 hours, range 1200-2400 mg) or indomethacin (25-50 mg every 8 hours) should be used at full doses until complete symptom resolution 2
  • Add colchicine (0.5 mg twice daily for patients ≥70 kg or 0.5 mg once daily for patients <70 kg) to aspirin/NSAIDs for at least 3 months for acute pericarditis and 6 months for recurrent pericarditis 2, 1
  • Treatment duration should be guided by symptoms and C-reactive protein (CRP) normalization 2
  • Gastroprotection should be considered when using high-dose NSAIDs or aspirin 1

Treatment Algorithm

  1. Initial therapy: High-dose NSAIDs/aspirin + colchicine + exercise restriction 2
  2. Monitoring: Use CRP levels to guide treatment duration and assess response 2
  3. Tapering: After CRP normalization, gradually taper medications by decreasing doses (e.g., aspirin by 250-500 mg every 1-2 weeks) 2

Second-Line Treatment

  • Low-dose corticosteroids (prednisone 0.2-0.5 mg/kg/day) should be used only when:
    • Contraindications to aspirin/NSAIDs/colchicine exist 2
    • First-line therapy fails 2
    • Infectious causes have been excluded 2
  • Corticosteroids are not recommended as first-line therapy due to increased risk of chronicity and recurrence 2

Third-Line Treatment

  • For corticosteroid-dependent recurrent pericarditis not responsive to colchicine, consider:
    • Intravenous immunoglobulin (IVIG) 2, 3
    • Anakinra (IL-1 receptor antagonist) 2, 3, 4
    • Azathioprine 2, 3

Fourth-Line Treatment

  • Pericardiectomy may be considered as a last resort after thorough trial of unsuccessful medical therapy 2, 3

Special Considerations

Exercise Restrictions

  • Non-athletes: Restrict exercise until symptom resolution and CRP normalization 2
  • Athletes: Restrict exercise for at least 3 months until symptom resolution and normalization of CRP, ECG, and echocardiogram 2

Myopericarditis Management

  • Similar to pericarditis management but some authors recommend reduced NSAID dosages 2
  • Rest and avoidance of physical activity beyond normal sedentary activities is recommended 2
  • Return to physical exercise contraindicated for at least 6 months from illness onset 2

Prognosis and Complications

  • Recurrence rates: 15-30% after initial episode without colchicine, increasing to 50% after first recurrence 2, 4
  • Risk of constrictive pericarditis varies by etiology:
    • Low (<1%) for idiopathic/viral pericarditis 2, 1
    • Intermediate (2-5%) for autoimmune/neoplastic causes 2
    • High (20-30%) for bacterial etiologies 2
  • Cardiac tamponade is rare in idiopathic pericarditis but more common with specific etiologies like malignancy or purulent pericarditis 2

Common Pitfalls

  • Inadequate treatment of the first episode is a common cause of recurrence 2
  • Corticosteroids provide rapid symptom control but increase risk of chronicity and recurrence 1
  • Tapering medications too quickly can lead to symptom recurrence 2
  • When symptoms recur during therapy tapering, don't increase corticosteroid dose; instead maximize aspirin/NSAID dosing and ensure colchicine is being used 2

References

Guideline

Initial Treatment for Pericarditis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Alternative Treatments to Colchicine for Pericarditis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.